ホーム › がん（全種類） › インディアナ州 › Indianapolis
Indianapolis、INにおけるがん（全種類）の臨床試験
Indianapolisとその周辺地域（約30マイル以内）の拠点で、がん（全種類）に関する24件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Daily Hand-Held Vibration Therapy
被験者募集中
- Indiana University Melvin & Bren Simon Cancer Center, Indianapolis
- IU Health Joe & Shelly Schwarz Cancer Center, Indianapolis
- Indiana University Health West, Avon · 13マイル先
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
被験者募集中観察研究
- Indiana University, Indianapolis
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
被験者募集中第3相
- Franciscan Health Oncology and Hematology Specialists, Indianapolis
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
被験者募集中第3相
- Franciscan St. Francis Health /ID# 279788, Indianapolis
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
被験者募集中第1/2相
- Community Health Network, Indianapolis
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
被験者募集中第2相
- Community Health Network (The University of Texas MD Anderson Cancer Center), Indianapolis
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
被験者募集中第2/3相
- IN Univ Simon Cancer Center, Indianapolis
- Franciscan Health Indianapolis, Indianapolis
Collection of Tissue Samples for Cancer Research
被験者募集中観察研究
- Indiana University - Purdue, Indianapolis
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
被験者募集中第3相
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
- Community Cancer Center North, Indianapolis
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
被験者募集中第2相
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- Riley Hospital for Children, Indianapolis
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
Abatacept in Immune Checkpoint Inhibitor Myocarditis
被験者募集中第3相
- Franciscan Health, Indianapolis
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
被験者募集中第3相
- Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
- Sidney and Lois Eskenazi Hospital, Indianapolis
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
- 他1件
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
被験者募集中第1相
- Franciscan St. Francis Health /ID# 280928, Indianapolis
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
被験者募集中第2相
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
被験者募集中健康なボランティア歓迎
- Indiana University School of Medicine, Indianapolis
Childhood Cancer Survivor Study
被験者募集中観察研究健康なボランティア歓迎
- Indiana University/Riley Hospital for Children, Indianapolis
Galleri® in the Medicare Population.
被験者募集中健康なボランティア歓迎
- Community Health Network East, Indianapolis
- Community Health Network South, Indianapolis
The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
被験者募集中
- University Hospital Clinical Research Center, Indianapolis
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
被験者募集中
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
GEMINI-NSCLC: NSCLC Biomarker Study
被験者募集中観察研究
- Community Health Network, Indianapolis
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- IU Simon Comprehensive Cancer Center, Indianapolis
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
被験者募集中第1/2相
- Community Health Network, Inc., Indianapolis
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
被験者募集中
- Indiana University - Melvin and Bren Simon Cancer Center, Indianapolis
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Franciscan Health Indianapolis, Indianapolis
他の都市におけるがん（全種類）の試験
- Houston, TX121件の研究
- New York City, NY110件の研究
- Boston, MA86件の研究
- Los Angeles, CA73件の研究
- Nashville, TN65件の研究
- Philadelphia, PA59件の研究
- Durham, NC58件の研究
- Washington, DC58件の研究
- Chicago, IL51件の研究
- Seattle, WA49件の研究
- Atlanta, GA49件の研究
- Arlington, VA48件の研究
Indianapolisにおける他の研究
- 非小細胞肺癌32件の研究
- 心不全23件の研究
- 乳がん20件の研究
- 肥満症20件の研究
- 転移性癌19件の研究
- 大腸癌18件の研究
- 卵巣がん17件の研究
- 肺がん16件の研究
- 心血管疾患16件の研究
- 1型糖尿病14件の研究
- 子宮内膜がん14件の研究
- アルツハイマー病14件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。